Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2023 |
| Reihe/Periodikum: | The Lancet Regional Health - Europe ; volume 27, page 100592 ; ISSN 2666-7762 |
| Verlag/Hrsg.: |
Elsevier BV
|
| Schlagwörter: | Health Policy / Oncology / Internal Medicine |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-27192251 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1016/j.lanepe.2023.100592 |
